Global Drugs for Osteoarthritis Pain Market Growth (Status and Outlook) 2020-2025

November 2020 | 130 pages | ID: GF328D6913CEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

According to this study, over the next five years the Drugs for Osteoarthritis Pain market will register a 5.9%% CAGR in terms of revenue, the global market size will reach $ 10290 million by 2025, from $ 8174.6 million in 2019. In particular, this report presents the global revenue market share of key companies in Drugs for Osteoarthritis Pain business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Drugs for Osteoarthritis Pain market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Drugs for Osteoarthritis Pain, covering the supply chain analysis, impact assessment to the Drugs for Osteoarthritis Pain market size growth rate in several scenarios, and the measures to be undertaken by Drugs for Osteoarthritis Pain companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.

• Oral
• Injection
• External

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.

• Medical Care
• Personal Care

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

• Pfizer
• Mylan
• Johnson & Johnson
• Bayer
• Eli Lilly
• GlaxoSmithKline
• Horizon Pharma
• Novartis
• Abbott
• Sanofi
• Iroko Pharmaceuticals
• Abiogen Pharma
• Hengrui Pharmaceutical
• Daiichi Sankyo
• Astellas Pharma
• Almatica Pharma
• Tide Pharmaceutical
• TEVA

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Drugs for Osteoarthritis Pain market size by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
• To understand the structure of Drugs for Osteoarthritis Pain market by identifying its various subsegments.
• Focuses on the key global Drugs for Osteoarthritis Pain players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Drugs for Osteoarthritis Pain with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the size of Drugs for Osteoarthritis Pain submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Drugs for Osteoarthritis Pain Market Size 2015-2025
  2.1.2 Drugs for Osteoarthritis Pain Market Size CAGR by Region
2.2 Drugs for Osteoarthritis Pain Segment by Type
  2.2.1 Oral
  2.2.2 Oral
  2.2.3 External
2.3 Drugs for Osteoarthritis Pain Market Size by Type
  2.3.1 Global Drugs for Osteoarthritis Pain Market Size Market Share by Type (2015-2020)
  2.3.2 Global Drugs for Osteoarthritis Pain Market Size Growth Rate by Type (2015-2020)
2.4 Drugs for Osteoarthritis Pain Segment by Application
  2.4.1 Medical Care
  2.4.2 Personal Care
2.5 Drugs for Osteoarthritis Pain Market Size by Application
  2.5.1 Global Drugs for Osteoarthritis Pain Market Size Market Share by Application (2015-2020)
  2.5.2 Global Drugs for Osteoarthritis Pain Market Size Growth Rate by Application (2015-2020)

3 GLOBAL DRUGS FOR OSTEOARTHRITIS PAIN BY PLAYERS

3.1 Global Drugs for Osteoarthritis Pain Market Size Market Share by Players
  3.1.1 Global Drugs for Osteoarthritis Pain Market Size by Players (2018-2020)
  3.1.2 Global Drugs for Osteoarthritis Pain Market Size Market Share by Players (2018-2020)
3.2 Global Drugs for Osteoarthritis Pain Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 DRUGS FOR OSTEOARTHRITIS PAIN BY REGIONS

4.1 Drugs for Osteoarthritis Pain Market Size by Regions
4.2 Americas Drugs for Osteoarthritis Pain Market Size Growth
4.3 APAC Drugs for Osteoarthritis Pain Market Size Growth
4.4 Europe Drugs for Osteoarthritis Pain Market Size Growth
4.5 Middle East & Africa Drugs for Osteoarthritis Pain Market Size Growth

5 AMERICAS

5.1 Americas Drugs for Osteoarthritis Pain Market Size by Countries
5.2 Americas Drugs for Osteoarthritis Pain Market Size by Type
5.3 Americas Drugs for Osteoarthritis Pain Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Drugs for Osteoarthritis Pain Market Size by Regions
6.2 APAC Drugs for Osteoarthritis Pain Market Size by Type
6.3 APAC Drugs for Osteoarthritis Pain Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 EUROPE

7.1 Europe Drugs for Osteoarthritis Pain by Countries
7.2 Europe Drugs for Osteoarthritis Pain Market Size by Type
7.3 Europe Drugs for Osteoarthritis Pain Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Drugs for Osteoarthritis Pain by Countries
8.2 Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Type
8.3 Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 GLOBAL DRUGS FOR OSTEOARTHRITIS PAIN MARKET FORECAST

10.1 Global Drugs for Osteoarthritis Pain Market Size Forecast (2021-2025)
10.2 Global Drugs for Osteoarthritis Pain Forecast by Regions
  10.2.1 Global Drugs for Osteoarthritis Pain Forecast by Regions (2021-2025)
  10.2.2 Americas Market Forecast
  10.2.3 APAC Market Forecast
  10.2.4 Europe Market Forecast
  10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
  10.3.1 United States Market Forecast
  10.3.2 Canada Market Forecast
  10.3.3 Mexico Market Forecast
  10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
  10.4.1 China Market Forecast
  10.4.2 Japan Market Forecast
  10.4.3 Korea Market Forecast
  10.4.4 Southeast Asia Market Forecast
  10.4.5 India Market Forecast
  10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
  10.5.1 Germany Market Forecast
  10.5.2 France Market Forecast
  10.5.3 UK Market Forecast
  10.5.4 Italy Market Forecast
  10.5.5 Russia Market Forecast
  10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
  10.6.1 Egypt Market Forecast
  10.6.2 South Africa Market Forecast
  10.6.3 Israel Market Forecast
  10.6.4 Turkey Market Forecast
  10.6.5 GCC Countries Market Forecast
10.7 Global Drugs for Osteoarthritis Pain Forecast by Type
10.8 Global Drugs for Osteoarthritis Pain Forecast by Application

11 KEY PLAYERS ANALYSIS

11.1 Pfizer
  11.1.1 Company Details
  11.1.2 Drugs for Osteoarthritis Pain Product Offered
  11.1.3 Pfizer Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2018-2020)
  11.1.4 Main Business Overview
  11.1.5 Pfizer News
11.2 Mylan
  11.2.1 Company Details
  11.2.2 Drugs for Osteoarthritis Pain Product Offered
  11.2.3 Mylan Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2018-2020)
  11.2.4 Main Business Overview
  11.2.5 Mylan News
11.3 Johnson & Johnson
  11.3.1 Company Details
  11.3.2 Drugs for Osteoarthritis Pain Product Offered
  11.3.3 Johnson & Johnson Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2018-2020)
  11.3.4 Main Business Overview
  11.3.5 Johnson & Johnson News
11.4 Bayer
  11.4.1 Company Details
  11.4.2 Drugs for Osteoarthritis Pain Product Offered
  11.4.3 Bayer Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2018-2020)
  11.4.4 Main Business Overview
  11.4.5 Bayer News
11.5 Eli Lilly
  11.5.1 Company Details
  11.5.2 Drugs for Osteoarthritis Pain Product Offered
  11.5.3 Eli Lilly Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2018-2020)
  11.5.4 Main Business Overview
  11.5.5 Eli Lilly News
11.6 GlaxoSmithKline
  11.6.1 Company Details
  11.6.2 Drugs for Osteoarthritis Pain Product Offered
  11.6.3 GlaxoSmithKline Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2018-2020)
  11.6.4 Main Business Overview
  11.6.5 GlaxoSmithKline News
11.7 Horizon Pharma
  11.7.1 Company Details
  11.7.2 Drugs for Osteoarthritis Pain Product Offered
  11.7.3 Horizon Pharma Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2018-2020)
  11.7.4 Main Business Overview
  11.7.5 Horizon Pharma News
11.8 Novartis
  11.8.1 Company Details
  11.8.2 Drugs for Osteoarthritis Pain Product Offered
  11.8.3 Novartis Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2018-2020)
  11.8.4 Main Business Overview
  11.8.5 Novartis News
11.9 Abbott
  11.9.1 Company Details
  11.9.2 Drugs for Osteoarthritis Pain Product Offered
  11.9.3 Abbott Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2018-2020)
  11.9.4 Main Business Overview
  11.9.5 Abbott News
11.10 Sanofi
  11.10.1 Company Details
  11.10.2 Drugs for Osteoarthritis Pain Product Offered
  11.10.3 Sanofi Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2018-2020)
  11.10.4 Main Business Overview
  11.10.5 Sanofi News
11.11 Iroko Pharmaceuticals
11.12 Abiogen Pharma
11.13 Hengrui Pharmaceutical
11.14 Daiichi Sankyo
11.15 Astellas Pharma
11.16 Almatica Pharma
11.17 Tide Pharmaceutical
11.18 TEVA

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Research Methodology
Table 2. Data Source
Table 3. Drugs for Osteoarthritis Pain Market Size CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Oral
Table 5. Major Players of Injection
Table 6. Major Players of External
Table 7. Drugs for Osteoarthritis Pain Market Size by Type (2014-2019) ($ Millions)
Table 8. Global Drugs for Osteoarthritis Pain Market Size Market Share by Type (2015-2020)
Table 9. Global Drugs for Osteoarthritis Pain Market Size by Application (2015-2020) ($ Millions)
Table 10. Global Drugs for Osteoarthritis Pain Market Size Market Share by Application (2015-2020)
Table 11. Global Drugs for Osteoarthritis Pain Revenue by Players (2018-2020) ($ Millions)
Table 12. Global Drugs for Osteoarthritis Pain Revenue Market Share by Players (2018-2020)
Table 13. Global Drugs for Osteoarthritis Pain Key Players Head office and Products Offered
Table 14. Drugs for Osteoarthritis Pain Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Drugs for Osteoarthritis Pain Market Size by Regions 2015-2020 ($ Millions)
Table 18. Global Drugs for Osteoarthritis Pain Market Size Market Share by Regions 2015-2020
Table 19. Americas Drugs for Osteoarthritis Pain Market Size by Countries (2015-2020) ($ Millions)
Table 20. Americas Drugs for Osteoarthritis Pain Market Size Market Share by Countries (2015-2020)
Table 21. Americas Drugs for Osteoarthritis Pain Market Size by Type (2015-2020) ($ Millions)
Table 22. Americas Drugs for Osteoarthritis Pain Market Size Market Share by Type (2015-2020)
Table 23. Americas Drugs for Osteoarthritis Pain Market Size by Application (2015-2020) ($ Millions)
Table 24. Americas Drugs for Osteoarthritis Pain Market Size Market Share by Application (2015-2020)
Table 25. APAC Drugs for Osteoarthritis Pain Market Size by Regions (2015-2020) ($ Millions)
Table 26. APAC Drugs for Osteoarthritis Pain Market Size Market Share by Regions (2015-2020)
Table 27. APAC Drugs for Osteoarthritis Pain Market Size by Type (2015-2020) ($ Millions)
Table 28. APAC Drugs for Osteoarthritis Pain Market Size Market Share by Type (2015-2020)
Table 29. APAC Drugs for Osteoarthritis Pain Market Size by Application (2015-2020) ($ Millions)
Table 30. APAC Drugs for Osteoarthritis Pain Market Size Market Share by Application (2015-2020)
Table 31. Europe Drugs for Osteoarthritis Pain Market Size by Countries (2015-2020) ($ Millions)
Table 32. Europe Drugs for Osteoarthritis Pain Market Size Market Share by Countries (2015-2020)
Table 33. Europe Drugs for Osteoarthritis Pain Market Size by Type (2015-2020) ($ Millions)
Table 34. Europe Drugs for Osteoarthritis Pain Market Size Market Share by Type (2015-2020)
Table 35. Europe Drugs for Osteoarthritis Pain Market Size by Application (2015-2020) ($ Millions)
Table 36. Europe Drugs for Osteoarthritis Pain Market Size Market Share by Application (2015-2020)
Table 37. Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Countries (2015-2020) ($ Millions)
Table 38. Middle East & Africa Drugs for Osteoarthritis Pain Market Size Market Share by Countries (2015-2020)
Table 39. Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Type (2015-2020) ($ Millions)
Table 40. Middle East & Africa Drugs for Osteoarthritis Pain Market Size Market Share by Type (2015-2020)
Table 41. Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Application (2015-2020) ($ Millions)
Table 42. Middle East & Africa Drugs for Osteoarthritis Pain Market Size Market Share by Application (2015-2020)
Table 43. Key and Potential Regions of Drugs for Osteoarthritis Pain
Table 44. Key Application and Potential Industries of Drugs for Osteoarthritis Pain
Table 45. Key Challenges of Drugs for Osteoarthritis Pain
Table 46. Key Trends of Drugs for Osteoarthritis Pain
Table 47. Global Drugs for Osteoarthritis Pain Market Size Forecast by Regions (2021-2025) ($ Millions)
Table 48. Global Drugs for Osteoarthritis Pain Market Size Market Share Forecast by Regions
Table 49. Global Drugs for Osteoarthritis Pain Market Size Forecast by Type (2021-2025) ($ Millions)
Table 50. Global Drugs for Osteoarthritis Pain Market Size Market Share Forecast by Type (2021-2025)
Table 51. Global Drugs for Osteoarthritis Pain Market Size Forecast by Application (2021-2025) ($ Millions)
Table 52. Global Drugs for Osteoarthritis Pain Market Size Market Share Forecast by Application (2021-2025)
Table 53. Pfizer Details, Company Total Revenue (in $ million), Head Office, Drugs for Osteoarthritis Pain Major Market Areas and Its Competitors
Table 54. Pfizer Drugs for Osteoarthritis Pain Product Offered
Table 55. Pfizer Drugs for Osteoarthritis Pain Revenue and Gross Margin (2018-2020E)
Table 56. Pfizer Main Business
Table 57. Pfizer Latest Developments
Table 58. Mylan Details, Company Total Revenue (in $ million), Head Office, Drugs for Osteoarthritis Pain Major Market Areas and Its Competitors
Table 59. Mylan Drugs for Osteoarthritis Pain Product Offered
Table 60. Mylan Main Business
Table 61. Mylan Drugs for Osteoarthritis Pain Revenue and Gross Margin (2018-2020E)
Table 62. Mylan Latest Developments
Table 63. Johnson & Johnson Details, Company Total Revenue (in $ million), Head Office, Drugs for Osteoarthritis Pain Major Market Areas and Its Competitors
Table 64. Johnson & Johnson Drugs for Osteoarthritis Pain Product Offered
Table 65. Johnson & Johnson Main Business
Table 66. Johnson & Johnson Drugs for Osteoarthritis Pain Revenue and Gross Margin (2018-2020E)
Table 67. Johnson & Johnson Latest Developments
Table 68. Bayer Details, Company Total Revenue (in $ million), Head Office, Drugs for Osteoarthritis Pain Major Market Areas and Its Competitors
Table 69. Bayer Drugs for Osteoarthritis Pain Product Offered
Table 70. Bayer Main Business
Table 71. Bayer Drugs for Osteoarthritis Pain Revenue and Gross Margin (2018-2020E)
Table 72. Bayer Latest Developments
Table 73. Eli Lilly Details, Company Total Revenue (in $ million), Head Office, Drugs for Osteoarthritis Pain Major Market Areas and Its Competitors
Table 74. Eli Lilly Drugs for Osteoarthritis Pain Product Offered
Table 75. Eli Lilly Main Business
Table 76. Eli Lilly Drugs for Osteoarthritis Pain Revenue and Gross Margin (2018-2020E)
Table 77. Eli Lilly Latest Developments
Table 78. GlaxoSmithKline Details, Company Total Revenue (in $ million), Head Office, Drugs for Osteoarthritis Pain Major Market Areas and Its Competitors
Table 79. GlaxoSmithKline Drugs for Osteoarthritis Pain Product Offered
Table 80. GlaxoSmithKline Main Business
Table 81. GlaxoSmithKline Drugs for Osteoarthritis Pain Revenue and Gross Margin (2018-2020E)
Table 82. GlaxoSmithKline Latest Developments
Table 83. Horizon Pharma Details, Company Total Revenue (in $ million), Head Office, Drugs for Osteoarthritis Pain Major Market Areas and Its Competitors
Table 84. Horizon Pharma Drugs for Osteoarthritis Pain Product Offered
Table 85. Horizon Pharma Main Business
Table 86. Horizon Pharma Drugs for Osteoarthritis Pain Revenue and Gross Margin (2018-2020E)
Table 87. Horizon Pharma Latest Developments
Table 88. Novartis Details, Company Total Revenue (in $ million), Head Office, Drugs for Osteoarthritis Pain Major Market Areas and Its Competitors
Table 89. Novartis Drugs for Osteoarthritis Pain Product Offered
Table 90. Novartis Main Business
Table 91. Novartis Drugs for Osteoarthritis Pain Revenue and Gross Margin (2018-2020E)
Table 92. Novartis Latest Developments
Table 93. Abbott Details, Company Total Revenue (in $ million), Head Office, Drugs for Osteoarthritis Pain Major Market Areas and Its Competitors
Table 94. Abbott Drugs for Osteoarthritis Pain Product Offered
Table 95. Abbott Main Business
Table 96. Abbott Drugs for Osteoarthritis Pain Revenue and Gross Margin (2018-2020E)
Table 97. Abbott Latest Developments
Table 98. Sanofi Details, Company Total Revenue (in $ million), Head Office, Drugs for Osteoarthritis Pain Major Market Areas and Its Competitors
Table 99. Sanofi Drugs for Osteoarthritis Pain Product Offered
Table 100. Sanofi Main Business
Table 101. Sanofi Drugs for Osteoarthritis Pain Revenue and Gross Margin (2018-2020E)
Table 102. Sanofi Latest Developments
Table 103. Iroko Pharmaceuticals Details, Company Total Revenue (in $ million), Head Office, Drugs for Osteoarthritis Pain Major Market Areas and Its Competitors
Table 104. Abiogen Pharma Details, Company Total Revenue (in $ million), Head Office, Drugs for Osteoarthritis Pain Major Market Areas and Its Competitors
Table 105. Hengrui Pharmaceutical Details, Company Total Revenue (in $ million), Head Office, Drugs for Osteoarthritis Pain Major Market Areas and Its Competitors
Table 106. Daiichi Sankyo Details, Company Total Revenue (in $ million), Head Office, Drugs for Osteoarthritis Pain Major Market Areas and Its Competitors
Table 107. Astellas Pharma Details, Company Total Revenue (in $ million), Head Office, Drugs for Osteoarthritis Pain Major Market Areas and Its Competitors
Table 108. Almatica Pharma Details, Company Total Revenue (in $ million), Head Office, Drugs for Osteoarthritis Pain Major Market Areas and Its Competitors
Table 109. Tide Pharmaceutical Details, Company Total Revenue (in $ million), Head Office, Drugs for Osteoarthritis Pain Major Market Areas and Its Competitors
Table 110. TEVA Details, Company Total Revenue (in $ million), Head Office, Drugs for Osteoarthritis Pain Major Market Areas and Its Competitors

List Of Figures

LIST OF FIGURES

Figure 1. Drugs for Osteoarthritis Pain Report Years Considered
Figure 2. Market Research Methodology
Figure 3. Global Drugs for Osteoarthritis Pain Market Size Growth Rate 2015-2025 ($ Millions)
Figure 4. Global Drugs for Osteoarthritis Pain Market Size Market Share by Type (2015-2020)
Figure 5. Global Oral Market Size Growth Rate
Figure 6. Global Injection Market Size Growth Rate
Figure 7. Global External Market Size Growth Rate
Figure 8. Drugs for Osteoarthritis Pain in Medical Care
Figure 9. Global Drugs for Osteoarthritis Pain Market: Medical Care (2015-2020) ($ Millions)
Figure 10. Drugs for Osteoarthritis Pain in Personal Care
Figure 11. Global Drugs for Osteoarthritis Pain Market: Personal Care (2015-2020) ($ Millions)
Figure 12. Global Drugs for Osteoarthritis Pain Market Size Market Share by Application in 2019
Figure 13. Global Drugs for Osteoarthritis Pain Market Size Market Share by Regions 2015-2020
Figure 14. Americas Drugs for Osteoarthritis Pain Market Size 2015-2020 ($ Millions)
Figure 15. APAC Drugs for Osteoarthritis Pain Market Size 2015-2020 ($ Millions)
Figure 16. Europe Drugs for Osteoarthritis Pain Market Size 2015-2020 ($ Millions)
Figure 17. Middle East & Africa Drugs for Osteoarthritis Pain Market Size 2015-2020 ($ Millions)
Figure 18. Americas Drugs for Osteoarthritis Pain Market Size Market Share by Countries in 2019
Figure 19. Americas Drugs for Osteoarthritis Pain Market Size Market Share by Type in 2019
Figure 20. Americas Drugs for Osteoarthritis Pain Market Size Market Share by Application in 2019
Figure 21. United States Drugs for Osteoarthritis Pain Market Size Growth 2015-2020 ($ Millions)
Figure 22. Canada Drugs for Osteoarthritis Pain Market Size Growth 2015-2020 ($ Millions)
Figure 23. Mexico Drugs for Osteoarthritis Pain Market Size Growth 2015-2020 ($ Millions)
Figure 24. APAC Drugs for Osteoarthritis Pain Market Size Market Share by Regions in 2019
Figure 25. APAC Drugs for Osteoarthritis Pain Market Size Market Share by Type in 2019
Figure 26. APAC Drugs for Osteoarthritis Pain Market Size Market Share by Application in 2019
Figure 27. China Drugs for Osteoarthritis Pain Market Size Growth 2015-2020 ($ Millions)
Figure 28. Japan Drugs for Osteoarthritis Pain Market Size Growth 2015-2020 ($ Millions)
Figure 29. Korea Drugs for Osteoarthritis Pain Market Size Growth 2015-2020 ($ Millions)
Figure 30. Southeast Asia Drugs for Osteoarthritis Pain Market Size Growth 2015-2020 ($ Millions)
Figure 31. India Drugs for Osteoarthritis Pain Market Size Growth 2015-2020 ($ Millions)
Figure 32. Australia Drugs for Osteoarthritis Pain Market Size Growth 2015-2020 ($ Millions)
Figure 33. Europe Drugs for Osteoarthritis Pain Market Size Market Share by Countries in 2019
Figure 34. Europe Drugs for Osteoarthritis Pain Market Size Market Share by Type in 2019
Figure 35. Europe Drugs for Osteoarthritis Pain Market Size Market Share by Application in 2019
Figure 36. Germany Drugs for Osteoarthritis Pain Market Size Growth 2015-2020 ($ Millions)
Figure 37. France Drugs for Osteoarthritis Pain Market Size Growth 2015-2020 ($ Millions)
Figure 38. UK Drugs for Osteoarthritis Pain Market Size Growth 2015-2020 ($ Millions)
Figure 39. Italy Drugs for Osteoarthritis Pain Market Size Growth 2015-2020 ($ Millions)
Figure 40. Russia Drugs for Osteoarthritis Pain Market Size Growth 2015-2020 ($ Millions)
Figure 41. Spain Drugs for Osteoarthritis Pain Market Size Growth 2015-2020 ($ Millions)
Figure 42. Middle East & Africa Drugs for Osteoarthritis Pain Market Size Market Share by Countries in 2019
Figure 43. Middle East & Africa Drugs for Osteoarthritis Pain Market Size Market Share by Type in 2019
Figure 44. Middle East & Africa Drugs for Osteoarthritis Pain Market Size Market Share by Application in 2019
Figure 45. Egypt Drugs for Osteoarthritis Pain Market Size Growth 2015-2020 ($ Millions)
Figure 46. South Africa Drugs for Osteoarthritis Pain Market Size Growth 2015-2020 ($ Millions)
Figure 47. Israel Drugs for Osteoarthritis Pain Market Size Growth 2015-2020 ($ Millions)
Figure 48. Turkey Drugs for Osteoarthritis Pain Market Size Growth 2015-2020 ($ Millions)
Figure 49. GCC Countries Drugs for Osteoarthritis Pain Market Size Growth 2015-2020 ($ Millions)
Figure 50. Global Drugs for Osteoarthritis Pain arket Size Forecast (2021-2025) ($ Millions)
Figure 51. Americas Drugs for Osteoarthritis Pain Market Size 2021-2025 ($ Millions)
Figure 52. APAC Drugs for Osteoarthritis Pain Market Size 2021-2025 ($ Millions)
Figure 53. Europe Drugs for Osteoarthritis Pain Market Size 2021-2025 ($ Millions)
Figure 54. Middle East & Africa Drugs for Osteoarthritis Pain Market Size 2021-2025 ($ Millions)
Figure 55. United States Drugs for Osteoarthritis Pain Market Size 2021-2025 ($ Millions)
Figure 56. Canada Drugs for Osteoarthritis Pain Market Size 2021-2025 ($ Millions)
Figure 57. Mexico Drugs for Osteoarthritis Pain Market Size 2021-2025 ($ Millions)
Figure 58. Brazil Drugs for Osteoarthritis Pain Market Size 2021-2025 ($ Millions)
Figure 59. China Drugs for Osteoarthritis Pain Market Size 2021-2025 ($ Millions)
Figure 60. Japan Drugs for Osteoarthritis Pain Market Size 2021-2025 ($ Millions)
Figure 61. Korea Drugs for Osteoarthritis Pain Market Size 2021-2025 ($ Millions)
Figure 62. Southeast Asia Drugs for Osteoarthritis Pain Market Size 2021-2025 ($ Millions)
Figure 63. India Drugs for Osteoarthritis Pain Market Size 2021-2025 ($ Millions)
Figure 64. Australia Drugs for Osteoarthritis Pain Market Size 2021-2025 ($ Millions)
Figure 65. Germany Drugs for Osteoarthritis Pain Market Size 2021-2025 ($ Millions)
Figure 66. France Drugs for Osteoarthritis Pain Market Size 2021-2025 ($ Millions)
Figure 67. UK Drugs for Osteoarthritis Pain Market Size 2021-2025 ($ Millions)
Figure 68. Italy Drugs for Osteoarthritis Pain Market Size 2021-2025 ($ Millions)
Figure 69. Russia Drugs for Osteoarthritis Pain Market Size 2021-2025 ($ Millions)
Figure 70. Spain Drugs for Osteoarthritis Pain Market Size 2021-2025 ($ Millions)
Figure 71. Egypt Drugs for Osteoarthritis Pain Market Size 2021-2025 ($ Millions)
Figure 72. South Africa Drugs for Osteoarthritis Pain Market Size 2021-2025 ($ Millions)
Figure 73. Israel Drugs for Osteoarthritis Pain Market Size 2021-2025 ($ Millions)
Figure 74. Turkey Drugs for Osteoarthritis Pain Market Size 2021-2025 ($ Millions)
Figure 75. GCC Countries Drugs for Osteoarthritis Pain Market Size 2021-2025 ($ Millions)